Skip to main content

Palo Alto Investors LP

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1306923 PALO ALTO, CA

Position in SNDX

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$18,908,593
-$1,297,479 QoQ
Shares Held
864,986
0.0% QoQ
Ownership
0.969%
of shares outstanding
% of Portfolio
2.61%
of 13F equity value
Holder Rank
#37
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $594,195,112 across 39 Biotechnology names. SNDX ranks #11 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,908,593 864,986
2026-03-31 $20,206,072 864,986
2025-12-31 $16,692,592 794,507
2025-09-30 $10,076,098 654,930
2025-06-30 $4,161,496 444,367
2025-03-31 $5,459,048 444,367
2024-12-31 $5,356,651 405,193
2024-09-30 $7,799,965 405,193
2024-06-30 $8,318,612 405,193
2024-03-31 $9,643,593 405,193
2023-12-31 $10,212,886 472,600
2023-09-30 $6,862,152 472,600
2023-06-30 $12,821,718 612,600
2023-03-31 $12,938,112 612,600
2022-12-31 $15,590,670 612,600
2022-09-30 $14,720,778 612,600
2022-06-30 $11,786,424 612,600
2022-03-31 $10,646,988 612,600
2021-12-31 $13,109,921 598,900
2021-09-30 $8,502,039 444,900
2021-06-30 $6,886,887 401,100
2021-03-31 $5,907,512 264,200
2020-12-31 $5,875,808 264,200
2020-09-30 $2,928,384 198,400
2020-06-30 $1,892,514 127,700
2020-03-31 $725,117 66,100